Ar - androgen receptor Gene

Mus musculus

Also known as Tfm

Gene ID: 11835 | Gene type: protein coding

About Ar

Chromosome X: 97,192,375-97,366,821 forward strand.GRCm39:CM001013.3

This gene has 1 transcript (splice variant), 277 orthologues, 8 paralogues and is associated with 89 phenotypes. Biased expression in adrenal adult (RPKM 4.7), genital fat pad adult (RPKM 4.4) and 12 other tissues.

Summary

This gene encodes a nuclear hormone receptor containing zinc finger and DNA-binding domains. The encoded protein is a key regulator of signalling by androgens, a class of steroid Hormones involved in male reproductive development. The protein responds to hormone signalling by translocating to the nucleus, forming dimers, and binding to androgen response elements (AREs) in the promoters of target genes, which are subsequently transcriptionally activated. Activity of this protein is negatively regulated by nuclear receptor subfamily 0 group B member 1 (Nr0b1, also known as Dax1). Mutations in this gene result in feminized genitals and infertility in male Animals. Loss of function in female Animals also causes problems in reproductive development and function. [provided by RefSeq, May 2015]

Ar Products(1)

mRNA	Protein	Name
NM_013476.4	NP_038504.1	androgen receptor

Gene Ontology

Molecular Function
Biological Process
Cellular Component

Molecular Function GO Annotation	Evidence	Reference	Source
enables DNA-binding transcription factor activity	IDA IDA: Inferred from direct assay	12145204	MGI
enables POU domain binding	IDA IDA: Inferred from direct assay	11997177	MGI
enables RNA polymerase II core promoter sequence-specific DNA binding	IDA IDA: Inferred from direct assay	27959439	MGI
enables enzyme binding	IPI IPI: Inferred from physical interaction	17277772	MGI
enables nuclear receptor activity	IDA IDA: Inferred from direct assay	12145204	MGI
enables protein binding	IPI IPI: Inferred from physical interaction	11997177	MGI
enables sequence-specific DNA binding	IDA IDA: Inferred from direct assay	8119157	MGI

Biological Process GO Annotation	Evidence	Reference	Source
acts upstream of or within Leydig cell differentiation	IMP IMP: Inferred from mutant phenotype	19574395	MGI
acts upstream of MAPK cascade	IMP IMP: Inferred from mutant phenotype	14676301	MGI
acts upstream of or within androgen receptor signaling pathway	IDA IDA: Inferred from direct assay	15199138	MGI
involved in androgen receptor signaling pathway	IDA IDA: Inferred from direct assay	18761815	MGI
acts upstream of or within animal organ formation	IMP IMP: Inferred from mutant phenotype	17317769	MGI
involved in cellular response to testosterone stimulus	IDA IDA: Inferred from direct assay	18761815	MGI
acts upstream of or within epithelial cell differentiation involved in prostate gland development	IMP IMP: Inferred from mutant phenotype	17652515	MGI
acts upstream of or within epithelial cell morphogenesis	IGI IGI: Inferred from genetic interaction	21084446	MGI
acts upstream of epithelial cell proliferation	IMP IMP: Inferred from mutant phenotype	17652515	MGI
acts upstream of estrogen receptor signaling pathway	IMP IMP: Inferred from mutant phenotype	14676301	MGI
acts upstream of or within fertilization	IMP IMP: Inferred from mutant phenotype	19574395	MGI
acts upstream of or within gene expression	IMP IMP: Inferred from mutant phenotype	27959439	MGI
acts upstream of or within in utero embryonic development	IMP IMP: Inferred from mutant phenotype	10319319	MGI
acts upstream of insulin-like growth factor receptor signaling pathway	IMP IMP: Inferred from mutant phenotype	14676301	MGI
acts upstream of or within lateral sprouting involved in mammary gland duct morphogenesis	IMP IMP: Inferred from mutant phenotype	14676301	MGI
acts upstream of or within male genitalia morphogenesis	IMP IMP: Inferred from mutant phenotype	19282366	MGI
acts upstream of or within male gonad development	IGI IGI: Inferred from genetic interaction	21084446	MGI
acts upstream of or within male gonad development	IMP IMP: Inferred from mutant phenotype	10319319	MGI
acts upstream of or within male somatic sex determination	IMP IMP: Inferred from mutant phenotype	5452809	MGI
acts upstream of or within mammary gland alveolus development	IMP IMP: Inferred from mutant phenotype	14676301	MGI
acts upstream of or within morphogenesis of an epithelial fold	IMP IMP: Inferred from mutant phenotype	17652515	MGI
acts upstream of or within multicellular organism growth	IGI IGI: Inferred from genetic interaction	19574395	MGI
acts upstream of or within negative regulation of epithelial cell proliferation	IMP IMP: Inferred from mutant phenotype	17652515	MGI
acts upstream of or within positive regulation of MAPK cascade	IMP IMP: Inferred from mutant phenotype	14676301	MGI
acts upstream of or within positive regulation of epithelial cell proliferation involved in prostate gland development	IDA IDA: Inferred from direct assay	11535819	MGI
acts upstream of or within positive regulation of insulin-like growth factor receptor signaling pathway	IMP IMP: Inferred from mutant phenotype	14676301	MGI
acts upstream of or within positive regulation of intracellular estrogen receptor signaling pathway	IMP IMP: Inferred from mutant phenotype	14676301	MGI
acts upstream of or within positive regulation of transcription by RNA polymerase II	IDA IDA: Inferred from direct assay	16254014	MGI
acts upstream of or within positive regulation of transcription by RNA polymerase II	IGI IGI: Inferred from genetic interaction	16254014	MGI
acts upstream of or within positive regulation of transcription by RNA polymerase II	IMP IMP: Inferred from mutant phenotype	17332066	MGI
acts upstream of or within prostate gland epithelium morphogenesis	IMP IMP: Inferred from mutant phenotype	17652515	MGI
acts upstream of or within prostate gland growth	IMP IMP: Inferred from mutant phenotype	17317769	MGI
acts upstream of or within prostate induction	IMP IMP: Inferred from mutant phenotype	17317769	MGI
acts upstream of or within regulation of DNA-templated transcription	IDA IDA: Inferred from direct assay	12145204	MGI
acts upstream of or within regulation of developmental growth	IMP IMP: Inferred from mutant phenotype	17317769	MGI
acts upstream of or within regulation of gene expression	IMP IMP: Inferred from mutant phenotype	17332066	MGI
acts upstream of or within regulation of prostatic bud formation	IGI IGI: Inferred from genetic interaction	12941620	MGI
acts upstream of or within regulation of systemic arterial blood pressure	IGI IGI: Inferred from genetic interaction	18468998	MGI
acts upstream of or within regulation of transcription by RNA polymerase II	IMP IMP: Inferred from mutant phenotype	17332066	MGI
acts upstream of or within reproductive structure development	IMP IMP: Inferred from mutant phenotype	17317769	MGI
acts upstream of or within reproductive system development	IGI IGI: Inferred from genetic interaction	19574395	MGI
acts upstream of or within seminiferous tubule development	IGI IGI: Inferred from genetic interaction	21084446	MGI
acts upstream of or within seminiferous tubule development	IMP IMP: Inferred from mutant phenotype	19574395	MGI
acts upstream of or within single fertilization	IGI IGI: Inferred from genetic interaction	21084446	MGI
acts upstream of or within spermatogenesis	IMP IMP: Inferred from mutant phenotype	18403489	MGI
acts upstream of or within tertiary branching involved in mammary gland duct morphogenesis	IMP IMP: Inferred from mutant phenotype	14676301	MGI
acts upstream of transcription by RNA polymerase II	IDA IDA: Inferred from direct assay	21427128	MGI
acts upstream of transcription by RNA polymerase II	IGI IGI: Inferred from genetic interaction	21427128	MGI

Cellular Component GO Annotation	Evidence	Reference	Source
located in cytoplasm	IDA IDA: Inferred from direct assay	12145204	MGI
located in nucleus	IDA IDA: Inferred from direct assay	11105903	MGI
located in nucleus	IPI IPI: Inferred from physical interaction	14576337	MGI
located in plasma membrane	IDA IDA: Inferred from direct assay	18468998	MGI

EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

Ar Protein Structure

Androgen_recep

NR_DBD_AR

NR_LBD_AR

0
200
400
600
800
899 a.a.

Protein Preferred Names

Protein Names

androgen receptor

dihydrotestosterone receptor	nuclear receptor subfamily 3 group C member 4
testicular feminization

Ar Protein-protein interaction Information

Type Cross Intra	Protein Name	Protein ID	Interactor	Interactor Species	Interactor ID	Detection Method	Reference
Intra	Ar	P19091	Casp8	Mus musculus	O89110	Anti Bait CoIP	17170703

Cross: Cross-species interaction Intra: Intraspecies interaction

Related Agents

Approval

Bioactive Molecules (59)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-70002	Enzalutamide		99.96%	Unkown
HY-13715	Norepinephrine		99.43%	Unkown
HY-B0573	Propranolol hydrochloride	Antagonist	99.96%	Yes
HY-111372	Finerenone	Antagonist	99.66%	Unkown
HY-B0573B	Propranolol	Antagonist	99.87%	Yes
HY-N0378	D-Mannitol		99.93%	Yes
HY-10064	Ticagrelor	Antagonist	99.98%	Yes
HY-13715A	Norepinephrine hydrochloride		99.95%	Yes
HY-N0092	Inosine	Agonist	99.67%	Yes
HY-16985	Darolutamide	Antagonist	99.49%	Unkown
HY-16060	Apalutamide	Antagonist	99.93%	Unkown
HY-14249	Bicalutamide		99.85%	Unkown
HY-13613	Dutasteride		99.83%	Yes
HY-B1037	Salbutamol		99.92%	Yes
HY-13715B	Norepinephrine bitartrate monohydrate		99.76%	Unkown
HY-19638A	Cangrelor tetrasodium	Antagonist	99.92%	Unkown
HY-14300A	Vilanterol trifenatate	Agonist	99.61%	Unkown
HY-17627	Avacopan	Inhibitor	99.75%	Yes
HY-15746	Dobutamine hydrochloride	Agonist	99.91%	Yes
HY-10122	Silodosin	Antagonist	99.82%	Yes
HY-17042A	Cetirizine dihydrochloride	Antagonist	99.58%	Yes
HY-17497A	Acebutolol hydrochloride	Antagonist	99.63%	Unkown
HY-B0659A	Brimonidine tartrate	Agonist	99.57%	Yes
HY-17042	Cetirizine	Antagonist	99.51%	Yes
HY-14300	Vilanterol	Agonist	99.30%	Unkown
HY-N0138	Theobromine	Inhibitor	99.78%	Unkown
HY-12798B	Netarsudil hydrochloride	Inhibitor	99.77%	Unkown
HY-B0111	Drospirenone	Agonist	98.45%	Unkown
HY-B1114	Gliquidone		99.52%	Unkown
HY-B0004	Doxofylline		99.65%	Yes
HY-12798A	Netarsudil dimesylate		99.56%	Unkown
HY-14301	Olodaterol	Agonist	98.47%	Unkown
HY-14301A	Olodaterol hydrochloride	Agonist	98.87%	Unkown
HY-70002B	Enzalutamide carboxylic acid		98.11%	Unkown
HY-B0659	Brimonidine	Agonist	99.99%	Yes
HY-A0295	(R)-Propranolol hydrochloride	Antagonist	99.36%	Unkown
HY-B1486	Oxprenolol hydrochloride	Antagonist	99.86%	Unkown
HY-B1276	Metaproterenol hemisulfate	Agonist	99.86%	Unkown
HY-13715R	Norepinephrine (Standard)		/	Unkown
HY-B1016	Trapidil	Inhibitor	≥98.0%	Unkown
HY-B0484	Buflomedil hydrochloride	Antagonist	99.81%	Unkown
HY-12798	Netarsudil	Inhibitor	98.78%	Unkown
HY-13715C	Norepinephrine tartrate		99.45%	Yes
HY-B0010A	Arformoterol	Agonist	99.96%	Unkown
HY-U00205	Dopexamine hydrochloride	Agonist	99.71%	Unkown
HY-15746A	Dobutamine	Agonist	/	Unkown
HY-15746B	Dobutamine tartrate	Agonist	/	Unkown
HY-19638	Cangrelor	Antagonist	/	Unkown
HY-13613R	Dutasteride (Standard)		/	Unkown
HY-17497	Acebutolol	Antagonist	/	Unkown
HY-B0010D	Arformoterol tartrate	Agonist	/	Unkown
HY-B0484A	Buflomedil	Antagonist	/	Unkown
HY-B0659S	Brimonidine-d4	Agonist	/	Unkown
HY-B1037R	Salbutamol (Standard)		/	Unkown
HY-B1276A	Metaproterenol	Agonist	/	Unkown
HY-B1486A	Oxprenolol	Antagonist	/	Unkown
HY-B1562	Bopindolol		/	Unkown
HY-B0010E	Arformoterol maleate	Agonist	/	Unkown
HY-U00244	Benzquinamide	Inhibitor	/	Unkown

Clinical Phase

Bioactive Molecules (41)

Cat. No.	Product Name	Effect	Purity	Phase
HY-15758	3,3'-Diindolylmethane		99.93%	Phase 4
HY-N0378R	D-Mannitol (Standard)		/	Phase 4
HY-10211	Tanespimycin		99.01%	Phase 3
HY-13591	Piclidenoson		99.28%	Phase 3
HY-108449	Acoltremon	Agonist	99.90%	Phase 3
HY-12365	Namodenoson	Agonist	99.75%	Phase 3
HY-50289	Sorbinil	Inhibitor	99.85%	Phase 3
HY-Y0261A	Ammonium sulphate,≥99.0%,AR		99.3%	Phase 3
HY-15314	Ranirestat	Inhibitor	96.10%	Phase 3
HY-101479	Iclaprim	Inhibitor	99.49%	Phase 3
HY-70002S	Deutenzalutamide		99.81%	Phase 3
HY-105122	Zanoterone	Antagonist	/	Phase 3
HY-138641	Bavdegalutamide	Inhibitor	99.64%	Phase 2
HY-111784	Inobrodib	Inhibitor	99.94%	Phase 2
HY-106178	PMX-53	Antagonist	99.98%	Phase 2
HY-153342	Luxdegalutamide	Degrader	98.94%	Phase 2
HY-129393	Etrumadenant	Antagonist	99.76%	Phase 2
HY-101978	Ciforadenant	Antagonist	99.85%	Phase 2
HY-158101	BMS-986365	Degrader	99.92%	Phase 2
HY-101980	Imaradenant	Antagonist	99.68%	Phase 2
HY-100186	GSK-2881078	Modulator	99.74%	Phase 2
HY-15996	Seviteronel		99.83%	Phase 2
HY-123875A	Ralaniten triacetate	Inhibitor	98.79%	Phase 2
HY-109139	Taminadenant	Antagonist	99.84%	Phase 2
HY-115282A	JNJ-63576253	Antagonist	99.22%	Phase 2
HY-111024	2,2,5,7,8-Pentamethyl-6-Chromanol	Modulator	99.30%	Phase 2
HY-111151	AR-9281	Inhibitor	99.43%	Phase 2
HY-11027	MK-0773	Inhibitor	99.92%	Phase 2
HY-19687	Zopolrestat	Inhibitor	99.92%	Phase 2
HY-108235A	Lanicemine dihydrochloride	Antagonist	99.94%	Phase 2
HY-19436	Solabegron	Agonist	99.89%	Phase 2
HY-115282	JNJ-63576253 free base	Antagonist	/	Phase 2
HY-106186	GW-493838	Agonist	/	Phase 2
HY-106303	YT 146	Agonist	/	Phase 2
HY-12172	MK-8141	Inhibitor	/	Phase 2
HY-16055	Silatecan	Inhibitor	/	Phase 2
HY-U00371	AR-08	Agonist	/	Phase 2
HY-103169	SCH442416	Antagonist	99.68%	Phase 1
HY-16079	AZD3514	Inhibitor	99.00%	Phase 1
HY-N2037	Higenamine		98.91%	Phase 1
HY-125639	(rac)-AR-13503	Inhibitor	98.01%	Phase 1

Inhibitory Antibodies (2)

Cat. No.	Product Name	Effect	Purity	Phase
HY-P99551	Tosatoxumab		95.00%	Phase 3
HY-P99450	Avdoralimab	Inhibitor	95.16%	Phase 2

Pre-clinical Phase

Bioactive Molecules (489)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-145388	AU-15330		99.57%	Unkown
HY-13248	AR-C155858	Inhibitor	99.62%	Unkown
HY-134923	CA77.1	Inducer	99.98%	Unkown
HY-19532	ZM241385	Antagonist	99.45%	Unkown
HY-W187305	MASM7		99.85%	Unkown
HY-101106	AR7	Antagonist	99.38%	Unkown
HY-10512	AR-A014418	Inhibitor	99.14%	Unkown
HY-135794	11-Ketodihydrotestosterone	Agonist	98.03%	Unkown
HY-W015061	Phenylacetylglycine		99.63%	Unkown
HY-138161	JR14a	Antagonist	99.59%	Unkown
HY-N0790	Lupeol		≥98.0%	Unkown
HY-110136A	PMX 205 Trifluoroacetate	Antagonist	99.50%	Unkown
HY-12111	BMS-564929	Agonist	98.17%	Unkown
HY-116522	AR420626		98.29%	Unkown
HY-N0236	Corylin	Inhibitor	99.97%	Unkown
HY-130492	ARCC-4	Inhibitor	99.88%	Unkown
HY-110126	AR-C118925XX	Antagonist	≥99.0%	Unkown
HY-N1943	Ailanthone	Inhibitor	99.76%	Unkown
HY-N0166	Gramine		99.80%	Unkown
HY-145479	PROTAC AR-V7 degrader-1	Inhibitor	99.34%	Unkown
HY-148141	JPE-1375	Antagonist	99.94%	Unkown
HY-Y0537	Potassium chloride, AR, 99.5%		99.6%	Unkown
HY-116501	VPC-14449	Inhibitor	99.71%	Unkown
HY-19334	L755507	Agonist	98.33%	Unkown
HY-136242	UT-34	Degrader	98.61%	Unkown
HY-N0092S2	Inosine-13C5	Agonist	99.90%	Unkown
HY-10547	OSU-03012		98.88%	Unkown
HY-101986	BIIE-0246	Antagonist	99.10%	Unkown
HY-100348	EPI-001		98.87%	Unkown
HY-Y0332B	Potassium dihydrogen phosphate, AR,99.5%		99.60%	Unkown
HY-P1345A	TLQP-21 TFA	Agonist	99.90%	Unkown
HY-148771	MTX-23		99.90%	Unkown
HY-150102	EPI-7170	Antagonist	99.86%	Unkown
HY-109070	Ralaniten	Antagonist	99.78%	Unkown
HY-12023	GTx-007	Modulator	99.67%	Unkown
HY-13265	AR-42	Inducer	98.69%	Yes
HY-114936	Piericidin A	Inhibitor	≥99.0%	Unkown
HY-W093399	Ammonium bicarbonate,AR,99%		≥99.0%	Unkown
HY-N2908	Atraric acid		99.94%	Unkown
HY-133020	ARD-266	Inhibitor	99.94%	Unkown
HY-123012	Lubabegron	Modulator	98.21%	Unkown
HY-12798C	AR-13503		96.74%	Unkown
HY-149433	BWA-522	Inducer	99.93%	Unkown
HY-153152	DPTN dihydrochloride	Antagonist	98.66%	Unkown
HY-132292	ARD-2128	Inhibitor	99.40%	Unkown
HY-161409	SC912		99.13%	Unkown
HY-110012	SCH-202676 hydrobromide	Modulator	96.81%	Unkown
HY-145709	Ar-V7-IN-1	Inhibitor	99.88%	Unkown
HY-112257	S-23	Modulator	99.93%	Unkown
HY-15564	AR 231453	Agonist	99.70%	Unkown
HY-108250	(R)-Bicalutamide	Antagonist	99.94%	Unkown
HY-112052	Aminomalonic acid		98.87%	Unkown
HY-112895	UT-155	Antagonist	99.55%	Unkown
HY-131498	MOCAc-PLGL(Dpa)AR		99.86%	Unkown
HY-145237	BM213	Agonist	99.81%	Unkown
HY-114402	ARD-69	Antagonist	99.75%	Unkown
HY-117669	VPC-14228	Inhibitor	99.92%	Unkown
HY-124292	Honokiol DCA	Inhibitor	98.37%	Unkown
HY-N4089	Quercetin 3-gentiobioside	Inhibitor	99.92%	Unkown
HY-120006A	(rel)-AR234960	Agonist	99.42%	Unkown
HY-130992	Androgen receptor antagonist 1	Antagonist	99.71%	Unkown
HY-B0845	Prochloraz		99.77%	Unkown
HY-100554	BMY 7378		99.92%	Unkown
HY-19319	MI-136		99.04%	Unkown
HY-19337	Ketodarolutamide	Antagonist	98.72%	Unkown
HY-139644	MIPS521	Agonist	98.21%	Unkown
HY-133045	VHL Ligand 8		98.04%	Unkown
HY-153918	(R)-SKBG-1	Inhibitor	99.50%	Unkown
HY-30756	tert-Butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate		99.89%	Unkown
HY-103190	MRS1220	Antagonist	99.50%	Unkown
HY-139659	ARD-61		99.68%	Unkown
HY-N7043	Isosilybin A	Inducer	99.63%	Unkown
HY-18776	A2AR-agonist-1	Agonist	99.90%	Unkown
HY-110060	NDT 9513727	Antagonist	99.35%	Unkown
HY-111809	N6-Ethyladenosine	Agonist	99.90%	Unkown
HY-70002S1	Enzalutamide-d6	Antagonist	99.84%	Unkown
HY-B1876	Nicosulfuron	Inhibitor	97.15%	Unkown
HY-W110883	Xylenol orange tetrasodium salt, IND		≥95.0%	Unkown
HY-101986A	BIIE-0246 hydrochloride	Antagonist	≥99.0%	Unkown
HY-103180	2'-MeCCPA	Agonist	99.79%	Unkown
HY-112256	ACP-105	Modulator	98.99%	Unkown
HY-116214	Cyprodinil		99.36%	Unkown
HY-158113	CBPD-409	Degrader	94.08%	Unkown
HY-16758	Verosudil	Inhibitor	99.18%	Unkown
HY-P5123A	Arg-Glu(edans)-Ile-His-Pro-Phe-His-Pro-Phe-His-Leu-Val-Ile-His-Thr-Lys(dabcyl)-Arg TFA	Activator	98.75%	Unkown
HY-156111	ARD-1676	Degrader	99.36%	Unkown
HY-102076	0990CL		≥98.0%	Unkown
HY-103162	ANR94	Antagonist	/	Unkown
HY-120018	VPC-13566	Inhibitor	99.87%	Unkown
HY-12122A	AR-C102222 hydrochloride	Inhibitor	99.83%	Unkown
HY-164373	SC428		≥98.0%	Unkown
HY-W013249	Boc-piperazine-benzoic acid		97.42%	Unkown
HY-117992	BR103		99.75%	Unkown
HY-130845A	AR antagonist 1 hydrochloride	Antagonist	99.53%	Unkown
HY-131388	ABM-14		98.17%	Unkown
HY-160777	VNPP433-3β	Degrader	98.01%	Unkown
HY-B0573S1	Propranolol-d7 (ring-d7)	Antagonist	99.38%	Unkown
HY-B0846	Dimethomorph	Inhibitor	99.13%	Unkown
HY-N2673	5-Heptadecylresorcinol	Activator	99.83%	Unkown
HY-101039A	AR-M 1000390 hydrochloride	Agonist	99.05%	Unkown
HY-101300	Cirazoline hydrochloride	Agonist	99.65%	Unkown
HY-101854	N6-(2-Phenylethyl)adenosine	Agonist	99.41%	Unkown
HY-103245	Cl-4AS-1	Agonist	99.2%	Unkown
HY-135483A	AR-R17779 hydrochloride	Agonist	≥99.0%	Unkown
HY-135732	SK33	Antagonist	99.98%	Unkown
HY-141487	CLP-3094	Inhibitor	≥95.0%	Unkown
HY-14250	PF-998425	Antagonist	98.31%	Unkown
HY-149862	ARD-2051	Degrader	98.19%	Unkown
HY-159190	HRX-0233	Inhibitor	/	Unkown
HY-16060S	Apalutamide-d4	Antagonist	99.90%	Unkown
HY-161369	CBPD-268	Degrader	/	Unkown
HY-161741	VinclozolinM2-2204	Degrader	98.00%	Unkown
HY-162412	PROTAC AR/AR-V7 degrader-1		99.72%	Unkown
HY-B1866	Linuron	Antagonist	99.88%	Unkown
HY-N0138S1	Theobromine-d3	Inhibitor	99.78%	Unkown
HY-N6703	ar-Turmerone	Inducer	98.52%	Unkown
HY-N7045	Isosilybin B		99.32%	Unkown
HY-101393A	CGP 12177 hydrochloride	Modulator	99.69%	Unkown
HY-133127	AR453588	Activator	99.84%	Unkown
HY-103183	CV1808	Agonist	≥98.0%	Unkown
HY-15011	L-372662	Antagonist	99.24%	Unkown
HY-151231	6-Hydroxyluteolin	Inhibitor	98.15%	Unkown
HY-160020	ET516	Inhibitor	/	Unkown
HY-162325	WJ-39		99.60%	Unkown
HY-163340	GA32	Inhibitor	99.67%	Unkown
HY-17042S	Cetirizine-d4	Antagonist	≥98.0%	Unkown
HY-17042S1	Cetirizine-d8	Antagonist	98.37%	Unkown
HY-B0573BS	Propranolol-d7	Antagonist	≥99.0%	Unkown
HY-B1001A	Todralazine hydrochloride	Inhibitor	99.87%	Unkown
HY-B1486S	Oxprenolol-d7 hydrochloride	Antagonist	98.25%	Unkown
HY-N0092S	Inosine-2,8-d2	Agonist	99.69%	Unkown
HY-P5506	C5a Receptor agonist, W5Cha	Agonist	99.50%	Unkown
HY-RS00884	Ar Mouse Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-W653723	N-Nitrosodicyclohexylamine	Antagonist	≥99.0%	Unkown
HY-135794S	11-Ketodihydrotestosterone-d3	Agonist	99.00%	Unkown
HY-151239	ONT-993	Inhibitor	99.85%	Unkown
HY-W111193A	Phosphotungstic acid hydrate,AR		/	Unkown
HY-111848	PROTAC AR Degrader-4	Inhibitor	/	Unkown
HY-111848A	PROTAC AR Degrader-4 TFA	Inhibitor	99.26%	Unkown
HY-111372A	(Rac)-Finerenone	Antagonist	99.66%	Unkown
HY-103246	TFM-4AS-1		99.96%	Unkown
HY-106954	Upidosin	Antagonist	99.58%	Unkown
HY-110136	PMX 205	Antagonist	/	Unkown
HY-111145	RD162	Antagonist	99.69%	Unkown
HY-113430	5-n-Heneicosylresorcinol	Inhibitor	≥98.0%	Unkown
HY-119996A	AR-C141990 hydrochloride	Inhibitor	≥98.0%	Unkown
HY-122917	Danshenol A	Inhibitor	99.67%	Unkown
HY-12715S	Yohimbine-13C,d3	Antagonist	≥99.0%	Unkown
HY-134983	Thalidomide-Piperazine 5-fluoride	Inducer	96.47%	Unkown
HY-136596	Apalutamide-COOH		99.14%	Unkown
HY-14250A	(Rac)-PF-998425	Antagonist	99.68%	Unkown
HY-144127	AR antagonist 3	Antagonist	99.96%	Unkown
HY-147100	α1A-AR Degrader 9c	Inhibitor	/	Unkown
HY-147291	VPC-70063		99.92%	Unkown
HY-147907	Adenosine receptor inhibitor 1	Inhibitor	/	Unkown
HY-151596	MAO-A/5-HT2AR-IN-1	Inhibitor	99.71%	Unkown
HY-151604	Transketolase-IN-3	Inhibitor	98.52%	Unkown
HY-153015	AAZ-A 154	Antagonist	≥98.0%	Unkown
HY-16060S1	Apalutamide-d3		/	Unkown
HY-16060S2	Apalutamide-13C,d3	Antagonist	99.90%	Unkown
HY-160887	FPT	Agonist	98.06%	Unkown
HY-162620	α2A-AR agonist 1	Agonist	/	Unkown
HY-163940	LX1	Inhibitor	99.13%	Unkown
HY-77734	AR-C133913XX		99.76%	Unkown
HY-90009D	(6S,12aR)-Tadalafil	Inhibitor	99.34%	Unkown
HY-D1606	BODIPY FL prazosin	Inhibitor	99.71%	Unkown
HY-N4232	Clematichinenoside AR	Inducer	≥99.0%	Unkown
HY-N7962	Cornoside	Inhibitor	≥96.0%	Unkown
HY-N9917	Galloylalbiflorin	Antagonist	≥95.0%	Unkown
HY-P5213	Vasopressin Dimer (parallel) (TFA)	Activator	99.55%	Unkown
HY-U00244A	Benzquinamide hydrochloride	Inhibitor	99.14%	Unkown
HY-W015061S	N-(Phenylacetyl-d5)glycine		≥99.0%	Unkown
HY-W110794	Crystal violet indicator (0.0-2.0), IND		/	Unkown
HY-P10639	C5aR2 agonist P32	Agonist	99.82%	Unkown
HY-14561	Idazoxan		/	Unkown
HY-101514	β3-AR agonist 1	Agonist	/	Unkown
HY-125839	OP-3633	Antagonist	/	Unkown
HY-133127A	AR453588 hydrochloride	Activator	/	Unkown
HY-14249S	Bicalutamide-d4		/	Unkown
HY-N0138S	Theobromine-d6	Inhibitor	≥98.0%	Unkown
HY-100348R	EPI-001 (Standard)		/	Unkown
HY-100661	Cetirizine Impurity D	Antagonist	/	Unkown
HY-101039	AR-M 1000390	Agonist	/	Unkown
HY-101986C	BIIE-0246 dihydrochloride	Antagonist	/	Unkown
HY-10273	Atecegatran metoxil	Inhibitor	/	Unkown
HY-10275A	Atecegatran TFA	Inhibitor	/	Unkown
HY-103177	PSB-10 hydrochloride	Inhibitor	/	Unkown
HY-103203	ST91	Agonist	99.75%	Unkown
HY-10512S	AR-A014418-d3	Inhibitor	/	Unkown
HY-106684A	Ridazolol hydrochloride	Antagonist	/	Unkown
HY-106769A	(3aR,9aR)-Fluparoxan hydrochloride		/	Unkown
HY-107018	AR-A 2	Antagonist	/	Unkown
HY-108633	BYK 49187	Inhibitor	/	Unkown
HY-108665	AR-C66096 tetrasodium	Antagonist	/	Unkown
HY-109139A	Taminadenant mesylate	Antagonist	/	Unkown
HY-110202	MRS5698	Agonist	/	Unkown
HY-111044	(+)-JNJ-37654032	Modulator	/	Unkown
HY-112006	(S)-ar-Curcumene		/	Unkown
HY-113781	Ractopamine	Agonist	/	Unkown
HY-115940	Aldose reductase-IN-2	Inhibitor	/	Unkown
HY-115977	Aldose reductase-IN-3	Inhibitor	/	Unkown
HY-116042	FSCPX	Antagonist	99.72%	Unkown
HY-116214R	Cyprodinil (Standard)		/	Unkown
HY-116214S	Cyprodinil-d5		/	Unkown
HY-116214S1	Cyprodinil-13C6		/	Unkown
HY-116379	RS-100329	Antagonist	/	Unkown
HY-117239	SB-206606	Agonist	/	Unkown
HY-117953	RU 59063	Inhibitor	/	Unkown
HY-117971	BVT173187	Inhibitor	/	Unkown
HY-118260	Phendioxan		/	Unkown
HY-118678	MRS1186	Antagonist	/	Unkown
HY-119806	TMPPAA	Agonist	/	Unkown
HY-119993	AR03	Inhibitor	/	Unkown
HY-119996	AR-C141990	Inhibitor	/	Unkown
HY-120090	MRS1177	Antagonist	/	Unkown
HY-120208	MK204	Inhibitor	/	Unkown
HY-120652	A3AR antagonist 3	Antagonist	/	Unkown
HY-12099	A3AR antagonist 2	Antagonist	/	Unkown
HY-121094	Androgen receptor allosteric antagonist 1	Antagonist	/	Unkown
HY-121588	IMTPPE	Inhibitor	/	Unkown
HY-122108	Ilicicolin A	Inducer	/	Unkown
HY-122231	MRS3558	Agonist	/	Unkown
HY-122963	Danshenol B		/	Unkown
HY-123012A	Lubabegron fumarate	Antagonist	/	Unkown
HY-123163	JNJ-1250132		/	Unkown
HY-123308	VPC13163	Inhibitor	/	Unkown
HY-123310	JNJ-26146900	Antagonist	/	Unkown
HY-124270	Sibenadet hydrochloride	Agonist	/	Unkown
HY-124412	Paynantheine	Agonist	/	Unkown
HY-125065	MK-4541		/	Unkown
HY-126464	Estromustine	Modulator	/	Unkown
HY-12716	BRL-44408	Antagonist	/	Unkown
HY-128934	Antitumor agent-2		/	Unkown
HY-133044	Boc-Pip-alkyne-Ph-COOH		/	Unkown
HY-133046	VHL Ligand-Linker Conjugates 17		/	Unkown
HY-133862	SCH-202676		/	Unkown
HY-13613S	Dutasteride-13C6		/	Unkown
HY-13613S2	Dutasteride-13C,15N,d		/	Unkown
HY-136960	β2AR antagonist 1	Antagonist	/	Unkown
HY-13715S	(Rac)-Norepinephrine-d3 formate		/	Unkown
HY-139104	Thailanstatin D		/	Unkown
HY-139694	hA3AR agonist 1	Agonist	/	Unkown
HY-139970	VPC-13789	Inhibitor	/	Unkown
HY-141865	Adenosine receptor antagonist 1	Antagonist	/	Unkown
HY-14249S1	Bicalutamide-d5		/	Unkown
HY-142923	AR antagonist 2	Antagonist	/	Unkown
HY-14300AS	Vilanterol-d4 trifenatate	Agonist	/	Unkown
HY-143471	WNY0824		/	Unkown
HY-143535	HG122		/	Unkown
HY-144115	A1AR antagonist 1	Antagonist	/	Unkown
HY-144116	A1AR antagonist 2	Antagonist	/	Unkown
HY-144672	A2A receptor antagonist 2	Antagonist	/	Unkown
HY-145308	Heterobivalent ligand-1		/	Unkown
HY-145406	IHCH-3064	Inhibitor	/	Unkown
HY-145480	Silodosin Glucuronide sodium		/	Unkown
HY-145698	UCSF678	Agonist	/	Unkown
HY-145699	UCSF686		/	Unkown
HY-145706	A2A/A1 AR antagonist-1	Antagonist	/	Unkown
HY-145862	5-HT6/5-HT2AR antagonist-1	Agonist	/	Unkown
HY-146026	Androgen receptor antagonist 3	Antagonist	/	Unkown
HY-146027	Androgen receptor antagonist 4	Antagonist	/	Unkown
HY-146397	TD-802	Inhibitor	/	Unkown
HY-146456	A1AR antagonist 3	Antagonist	/	Unkown
HY-146457	A3AR antagonist 1	Antagonist	/	Unkown
HY-146478	A1/A3 AR antagonist 1	Antagonist	/	Unkown
HY-146479	A1/A3 AR antagonist 2		/	Unkown
HY-146494	Androgen receptor antagonist 5	Antagonist	/	Unkown
HY-146979	hA2A/hCA XII modulator 1		/	Unkown
HY-147261	B026	Inhibitor	/	Unkown
HY-147541	A2A/A3 AR antagonist-1	Antagonist	/	Unkown
HY-147543	A1AR antagonist 4	Antagonist	/	Unkown
HY-147544	A1AR antagonist 5	Antagonist	/	Unkown
HY-147545	A1AR antagonist 6	Antagonist	/	Unkown
HY-147585	C5aR-IN-1		/	Unkown
HY-147586	C5aR-IN-2		/	Unkown
HY-147587	C5aR-IN-3		/	Unkown
HY-147706	AR524		/	Unkown
HY-147875	Aldose reductase-IN-6	Inhibitor	/	Unkown
HY-147908	Adenosine receptor inhibitor 2	Inhibitor	/	Unkown
HY-148252	ADRA1D receptor antagonist 1 free base	Antagonist	/	Unkown
HY-148361	Fluorogen binding modulator-1		/	Unkown
HY-148524	β2AR/M-receptor agonist-1		/	Unkown
HY-148525	PF-4348235		/	Unkown
HY-148526	β2AR/M3-receptor agonist-1	Agonist	/	Unkown
HY-148533	β2AR agonist /M-receptor antagonist-1		/	Unkown
HY-148777	A031	Degrader	/	Unkown
HY-14897	Rezatomidine	Agonist	/	Unkown
HY-149127	Rosolutamide		/	Unkown
HY-149434	PROTAC AR-NTD degrader 1	Inducer	/	Unkown
HY-149727	β2AR agonist 2	Agonist	/	Unkown
HY-149728	β2AR agonist 3	Agonist	/	Unkown
HY-149914	WCA-814	Degrader	/	Unkown
HY-149916	A2AR-antagonist-1	Antagonist	/	Unkown
HY-150025	(4aS,8aR)-NPD-001		/	Unkown
HY-151266	AR antagonist 4	Antagonist	/	Unkown
HY-151899	A3AR modulator 1	Agonist	/	Unkown
HY-152524	Androgen receptor antagonist 7	Antagonist	/	Unkown
HY-153333	A1/A3 AR antagonist 3	Antagonist	/	Unkown
HY-153519	WWL0245	Inhibitor	/	Unkown
HY-155183	A3AR agonist 1	Agonist	/	Unkown
HY-155184	A3AR agonist 2	Agonist	/	Unkown
HY-155543	Anticancer agent 135	Antagonist	/	Unkown
HY-155666	YXG-158	Degrader	/	Unkown
HY-155772	LUF7690		/	Unkown
HY-156084	LL-K9-3		/	Unkown
HY-156751	PROTAC AR Degrader-6	Degrader	/	Unkown
HY-156983	MRS 5980		/	Unkown
HY-157425	5-HT2CR agonist 1	Agonist	/	Unkown
HY-157455	AR antagonist 5		/	Unkown
HY-157491	K2-B4-5e	Degrader	/	Unkown
HY-157796	β2AR agonist 4	Agonist	/	Unkown
HY-158057	A2AR/A2BR antagonist 1	Antagonist	/	Unkown
HY-158179	A3AR agonist 3	Agonist	/	Unkown
HY-158180	A3AR agonist 4	Agonist	/	Unkown
HY-158181	A3AR agonist 5	Agonist	/	Unkown
HY-159096	Apoptosis inducer 21	Inducer	/	Unkown
HY-159889	hA3AR agonist 2	Agonist	/	Unkown
HY-159922	AR antagonist 9	Antagonist	/	Unkown
HY-160221	PROTAC AR Degrader-7		/	Unkown
HY-160262	AR/BET protein degrader-1	Degrader	/	Unkown
HY-160547	PROTAC AR Degrader-5		/	Unkown
HY-160680	AR antagonist 6	Inhibitor	/	Unkown
HY-160692	AR antagonist 7	Antagonist	/	Unkown
HY-161717	MRS5663	Agonist	/	Unkown
HY-161718	MRS8028	Agonist	/	Unkown
HY-161810	MRS8247	Modulator	/	Unkown
HY-161836	α2AR agonist 1	Agonist	/	Unkown
HY-162083	CB2R/5-HT1AR agonist 1	Agonist	/	Unkown
HY-162241	SJH1-62B	Degrader	/	Unkown
HY-162585	5-HT1AR agonist 1	Agonist	/	Unkown
HY-162659	β2AR ligand 1		/	Unkown
HY-162702	AZ'3137	Degrader	/	Unkown
HY-163363	β-AR antagonist 2	Antagonist	/	Unkown
HY-163378	C5aR1 antagonist 1	Antagonist	/	Unkown
HY-163379	C5aR1 antagonist 2	Antagonist	/	Unkown
HY-163485	AR antagonist 8	Inhibitor	/	Unkown
HY-163510	AR/AR-V7-IN-1	Inhibitor	/	Unkown
HY-163632	EGFR-IN-112	Inhibitor	/	Unkown
HY-163641	AR Degrader-1	Degrader	/	Unkown
HY-163813	AR Degrader-2	Degrader	/	Unkown
HY-163978	YGZ-331	Activator	/	Unkown
HY-16758A	Verosudil hydrochloride	Inhibitor	/	Unkown
HY-167905	ATL444	Antagonist	/	Unkown
HY-168141	Androgen receptor antagonist 11	Antagonist	/	Unkown
HY-168344	CACPD2011a-0001278239	Activator	/	Unkown
HY-169349	Androgen receptor antagonist 12	Antagonist	/	Unkown
HY-169385	ATC-324	Degrader	/	Unkown
HY-169386	YT 6-2 analog-1	Control	/	Unkown
HY-169387	YT 6-2-PEG3-C2-NH2	Control	/	Unkown
HY-169388	YT 6-2	Control	/	Unkown
HY-169394	5-HT1AR agonist 2		/	Unkown
HY-169975	tert-Butyl 4-(4-(piperazin-1-ylmethyl)piperidin-1-yl)benzoate		/	Unkown
HY-169976	E3 Ligase Ligand-linker Conjugate 140		/	Unkown
HY-170303	AR ligand-32		/	Unkown
HY-170304	E3 ligase Ligand 44		/	Unkown
HY-170305	E3 Ligase Ligand-linker Conjugate 145		/	Unkown
HY-170329	PROTAC AR Degrader-8		/	Unkown
HY-170330	AR ligand-33		/	Unkown
HY-17042AS1	Cetirizine-d8 dihydrochloride	Antagonist	/	Unkown
HY-170448	PROTAC AR Degrader-9	Degrader	/	Unkown
HY-170450	AR ligand-38	Ligand	/	Unkown
HY-19436A	Solabegron hydrochloride	Agonist	/	Unkown
HY-19532S	ZM241385-d7	Antagonist	/	Unkown
HY-78542S	Deshydroxyethoxy Ticagrelor-d7		/	Unkown
HY-B0010AS	Formoterol-d3	Agonist	/	Unkown
HY-B0573S	Propranolol-d7 hydrochloride	Antagonist	98.02%	Unkown
HY-B0846S	Dimethomorph-d8		/	Unkown
HY-B1001	Todralazine	Inhibitor	/	Unkown
HY-B1114S	Gliquidone-d6		/	Unkown
HY-B1486AS	Oxprenolol-d7	Antagonist	/	Unkown
HY-B1562B	Bopindolol (malonate)		/	Unkown
HY-B1562C	Bopindolol fumarate		/	Unkown
HY-D1379	Azophloxine		/	Unkown
HY-E70333	Rapidase Revelation Aroma (AR2000), Aspergillus niger		/	Unkown
HY-N0092S1	Inosine-13C	Agonist	/	Unkown
HY-N0092S3	Inosine-13C10,15N4	Agonist	/	Unkown
HY-N0166R	Gramine (Standard)		/	Unkown
HY-N10906	(4R,4aS,5aS,6aR,6bS,7aR)-4-Hydroxy-3,6b-dimethyl-5-methylene-4,4a,5,5a,6,6a,7,7a-octahydrocyclopropa[2,3]indeno[5,6-b]furan-2(6bH)-one		/	Unkown
HY-N11163	(Z)-(1R,3R,4R,4aS,8R,8aR)-3,4,8,8a-Tetramethyl-7-oxo-4-(2-(5-oxo-2,5-dihydrofuran-3-yl)ethyl)decahydronaphthalen-1-yl 2-methylbut-2-enoate		/	Unkown
HY-N3716	Dehydroglyasperin D	Inhibitor	/	Unkown
HY-N6703S	ar-Turmerone-d3	Inducer	/	Unkown
HY-N6883	6-Methoxytricin	Inhibitor	/	Unkown
HY-P1129	AR-M1896	Agonist	/	Unkown
HY-P1345	TLQP-21	Agonist	/	Unkown
HY-P1640	(Trp63,Trp64)-C3a(63-77)	Agonist	/	Unkown
HY-P3477	Mca-PLA-Nva-Dap(Dnp)-AR-NH2		/	Unkown
HY-P5010	(D-Arg8)-Inotocin	Antagonist	/	Unkown
HY-P5123	Arg-Glu(edans)-Ile-His-Pro-Phe-His-Pro-Phe-His-Leu-Val-Ile-His-Thr-Lys(dabcyl)-Arg	Activator	/	Unkown
HY-P5214	Vasopressin Dimer (anti-parallel) (TFA)	Activator	/	Unkown
HY-R01656	hsa-miR-548ar-3p mimic		/	Unkown
HY-R01656A	hsa-miR-548ar-3p agomir		/	Unkown
HY-R01657	hsa-miR-548ar-5p mimic		/	Unkown
HY-R01657A	hsa-miR-548ar-5p agomir		/	Unkown
HY-RI01656	hsa-miR-548ar-3p inhibitor		/	Unkown
HY-RI01656A	hsa-miR-548ar-3p antagomir		/	Unkown
HY-RI01657	hsa-miR-548ar-5p inhibitor		/	Unkown
HY-RI01657A	hsa-miR-548ar-5p antagomir		/	Unkown
HY-RS00883	AR Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS00885	Ar Rat Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS01744	C3AR1 Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS01750	C5AR1 Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS01751	C5AR2 Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-W093399S	Ammonium bicarbonate-15N		/	Unkown
HY-W1003189	E3 ligase Ligand 42		/	Unkown
HY-W140282	Angiotensin II antipeptide	Inhibitor	/	Unkown
HY-W471937	α1B-AR antagonist 1	Antagonist	/	Unkown
HY-W957364	Pomalidomide-C2-Br		/	Unkown
HY-Y0261AS	Ammonium sulphate-d8		/	Unkown
HY-Y0261AS1	Ammonium sulphate,≥99.0%,AR-N152		≥98.0%	Unkown
HY-Y0827	Barium carbonate,AR,99%		/	Unkown
HY-10122S	Silodosin-d4	Antagonist	/	Unkown
HY-101479S	Iclaprim-d6	Inhibitor	/	Unkown
HY-101977B	(3aR)-Selitrectinib	Inhibitor	/	Unkown
HY-10275	Atecegatran	Inhibitor	/	Unkown
HY-103163	(±)-5'-Chloro-5'-deoxy-ENBA	Agonist	/	Unkown
HY-106178D	PMX 53 monoacetate		/	Unkown
HY-106684	Ridazolol	Antagonist	/	Unkown
HY-106769B	(3aR,9aR)-Fluparoxan		/	Unkown
HY-111206	β3-AR agonist 3	Agonist	/	Unkown
HY-111273	AR244555	Antagonist	/	Unkown
HY-111372S	Finerenone-d3		/	Unkown
HY-111372S1	Finerenone-d5	Antagonist	/	Unkown
HY-114246	ONC1-13B		/	Unkown
HY-114602	AR-C117977	Inhibitor	/	Unkown
HY-115862	Benzo[c][1,8]naphthyridin-6(5H)-one	Inhibitor	/	Unkown
HY-116065	CUMI-101	Agonist	/	Unkown
HY-116508	MK 319	Inhibitor	/	Unkown
HY-118375	Phenylbutyl isoselenocyanate	Inducer	/	Unkown
HY-118944	L-748328	Antagonist	/	Unkown
HY-119088	Estrogen receptor modulator 12		/	Unkown
HY-12122	AR-C102222	Inhibitor	/	Unkown
HY-122048	AR-C67085		/	Unkown
HY-122053	Amidephrine hydrochloride	Inhibitor	/	Unkown
HY-122177	MK181	Inhibitor	/	Unkown
HY-123358	AR-H049020XX		/	Unkown
HY-125602	MNI-444		/	Unkown
HY-129761	AR 17048		/	Unkown
HY-130845	AR antagonist 1		/	Unkown
HY-131953	Androgen receptor-IN-3	Inhibitor	/	Unkown
HY-134555	A3AR antagonist 4	Antagonist	/	Unkown
HY-136702	L-97-1	Antagonist	/	Unkown
HY-153015A	AAZ-A 154 hydrobromide	Antagonist	/	Unkown
HY-153015B	AAZ-A 154 hydrochloride	Antagonist	/	Unkown
HY-153015C	AAZ-A 154 benzoate	Antagonist	/	Unkown
HY-153015D	AAZ-A 154 mesylate	Antagonist	/	Unkown
HY-154959A	(9R,12aR)-AZD4747		98.90%	Unkown
HY-155467	MRS7935	Modulator	/	Unkown
HY-15746S	(rac)-Dobutamine-d4 hydrochloride	Agonist	/	Unkown
HY-15746S1	(rac)-Dobutamine-d6 hydrochloride	Agonist	/	Unkown
HY-158882	FLAC6		/	Unkown
HY-159686	Aclidinium	Agonist	/	Unkown
HY-16060S3	Apalutamide-d7	Antagonist	/	Unkown
HY-162851	Adenosine receptor agonist 1	Agonist	/	Unkown
HY-164371	(+)-JJ-74-138	Antagonist	/	Unkown
HY-164477	FL442	Modulator	/	Unkown
HY-164552	ZNU-IMB-Z15		/	Unkown
HY-164621	A3AR antagonist 5	Antagonist	98.17%	Unkown
HY-165673S	9(S)-Hexahydrocannabinol-d9		/	Unkown
HY-166876S	Nicergoline impurity 18-d4		/	Unkown
HY-166887S	Tiotropium bromide impurity-d3		/	Unkown
HY-166898S	trans Nonachlor-13C10		/	Unkown
HY-166906S	cis-Nonachlor-13C10		/	Unkown
HY-168168	(5aS,6R,6aR)-MK-8666		/	Unkown
HY-168296	AR ligand-29		/	Unkown
HY-168299	AR ligand-30		/	Unkown
HY-168547S	AR89-d6	Inhibitor	/	Unkown
HY-168697	AR ligand-37		/	Unkown
HY-16985S	Darolutamide-d4	Antagonist	/	Unkown
HY-169966	Boc-CH2-O-(CH2)4-OTs		/	Unkown
HY-169967	AR ligand-31		/	Unkown
HY-19346	AR-13324 analog mesylate		≥98.0%	Unkown
HY-400766	BWA-522 intermediate-2		99.87%	Unkown
HY-401056	BWA-522 intermediate-3		/	Unkown
HY-A0052S	(1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-[(1R)-1-[2-(cyclopropylamino)-2-oxoacetyl]butyl]octahydrocyclopenta[c]pyrrole-1-carboxamide-d4		/	Unkown
HY-B1037B	Salbutamol adipate		/	Unkown
HY-B1276S	Metaproterenol-d7 hemisulfate	Agonist	/	Unkown
HY-N0092S4	Inosine-13C3	Agonist	/	Unkown
HY-N13308	8-Hydroxy-ar-turmerone		/	Unkown
HY-P10639A	C5aR2 agonist P32 acetate	Agonist	/	Unkown
HY-W110146	(3aS,4S,6aR)-Biotin-PEG4-Alkyne		99.93%	Unkown
HY-W130878	4-Octylphenol	Activator	/	Unkown
HY-W341547	3,4-Dihydro-6,7-isoquinolinediol	Agonist	/	Unkown
HY-W654262	10α-Methoxy-9,10-dihydrolysergol-d3		/	Unkown
HY-W728110	5-MeO-pyr-T	Agonist	/	Unkown
HY-W741999	Metaproterenol-d7-1 hemisulfate	Agonist	/	Unkown
HY-W743954	Nicergoline impurity 11-d3		/	Unkown
HY-W877989	BWA-522 intermediate-1		99.27%	Unkown
HY-Z7733	O-Desmethylcarvedilol	Inhibitor	/	Unkown
HY-U00391	β3-AR agonist 2	Agonist	/	Unkown

Inhibitory Antibodies (2)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-P99483	Blontuvetmab		99.08%	Unkown
HY-P990745	Izastobart	Ligand	/	Unkown

Orthologs Information

Species	Symbol	Source	ID
Homo sapiens	Ar	NCBI	NCBI:367
Canis familiaris	Ar	NCBI	NCBI:403588
Macaca fascicularis	Ar	NCBI	NCBI:102117720
Canis lupus familiaris	Ar	NCBI
Susscrofa domestica	Ar	NCBI
Leporidae	Ar	NCBI
Rattus norvegicus	Ar	NCBI	NCBI:24208
Macaca mulatta	Ar	NCBI	NCBI:574293

Name
Email *

	Sorry, but the email address you supplied was invalid.